Skip to main content
. 2017 Sep 30;36(3):257–263. doi: 10.23876/j.krcp.2017.36.3.257

Figure 1. Clinical course of patients.

Figure 1

Eight patients showed sustained remission without any oral medication after the last cycle of RTX treatment (A), and 10 patients had one or more episodes of relapses after the last cycle of RTX treatment (B).

CNI, calcineurin inhibitor; Pt, patient; RTX, rituximab.